Spring Bank Pharmaceuticals, Inc. (SBPH) Files Form 4 Insider Buying : Nezam H. Afdhal Buys 2,400 Shares

Spring Bank Pharmaceuticals, Inc. (SBPH): Nezam H. Afdhal , Chief Medical Officer of Spring Bank Pharmaceuticals, Inc. purchased 2,400 shares on Sep 9, 2016. The Insider buying transaction was reported by the company on Sep 12, 2016 to the Securities and Exchange Commission. The shares were purchased at $12.50 per share for a total value of $30,000.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 2, 2016, Martin J Driscoll (CEO) purchased 1,000 shares at $11.75 per share price.On Aug 24, 2016, Nezam H. Afdhal (Chief Medical Officer) purchased 2,000 shares at $11.96 per share price.Also, On Aug 24, 2016, Kurt M Eichler (director) purchased 3,000 shares at $10.73 per share price.On Aug 23, 2016, Jonathan Freve (CFO) purchased 1,000 shares at $10.74 per share price.

Leave a Reply

Spring Bank Pharmaceuticals, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Spring Bank Pharmaceuticals, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.